glp-1 obesity drug news today How Supply and Demand for Weight Loss Drugs is Playing Out in 2026 U.S. Obesity Rate Drops as
Description
Patients who develop symptoms of pancreatitis (e.g., upper abdominal pain radiating to the back, nausea, vomiting) should be evaluated promptly, and tirzepatide should be discontinued if pancreatitis is confirmed
Peer review Peer review information Nature Reviews Cardiology thanks Stephen Bain and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
The connection between sulfur burps and other GLP-1 side effects Sulfur burps rarely occur in isolation
Large epidemiological studies estimate that semaglutide use is associated with a two-fold increased risk of NAION
doi: 10.1002/hep.28431 3 LeoniSTovoliFNapoliLSerioIFerriSBolondiL
